Deteriorating ischaemic stroke: Cytokines, soluble cytokine receptors, ferritin, systemic blood pressure, body temperature, blood glucose, diabetes, stroke severity, and CT infarction-volume as predictors of deteriorating ischaemic stroke

Journal of the Neurological Sciences

Volumn 201, Issue 1-2, 2002, Pages 1-7

  Christensen, Hanne ^a   Boysen, Gudrun ^a   Johannesen, Helle Hjorth ^b   Christensen, Erik ^a   Bendtzen, Klaus ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

Blood glucose; Blood pressure; Body temperature; Cytokines; Deterioration; Ferritin; Stroke severity

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; FERRITIN; GLUCOSE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ARTICLE; BLOOD PRESSURE; BODY TEMPERATURE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DETERIORATION; DIABETES MELLITUS; DISEASE SEVERITY; FERRITIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RATING SCALE; SCORING SYSTEM;

BLOOD GLUCOSE; BLOOD PRESSURE; BODY TEMPERATURE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CYTOKINES; DIABETES MELLITUS; DISEASE PROGRESSION; FERRITINS; HUMANS; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECEPTORS, CYTOKINE; SEVERITY OF ILLNESS INDEX; SOLUBILITY;

EID: 0037105955     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00160-0     Document Type: Article

References (28)

1. Progressing neurological deficit secondary to acute ischemic stroke. A study on predictability, pathogenesis and prognosis
2. Progression of stroke after arrival at hospital
3. The use of anticoagulants in cerebral thrombosis
4. Tinzaparin in acute ischaemic stroke (TAIST): A randomised aspirin-controlled trial
5. Effectiveness of heparin treatment for progressing ischaemic stroke: Before and after study
6. Deteriorating ischemic stroke: Risk factors and prognosis
7. Effects of blood pressure and diabetes on stroke in progression
8. Progression of ischemic stroke and excitotoxic aminoacids
9. Nitric oxide-related brain damage in acute ischemic stroke
10. Proinflammatory cytokines and early neurological worsening in ischemic stroke
11. Body iron stores and early neurologic deterioration in acute cerebral infarction
12. Progression in acute stroke
13. Neurological deterioration in acute ischemic stroke. Potential predictors and associated factors in the European Cooperative Acute Stroke Study (ECASS)
14. Reliability of Scandinavian Neurological Stroke Scale
15. Interobserver agreement for the assessment of handicap in stroke patients
16. Reproduceability of measurements of cerebral infarct volume on CT Scans
17. Specific binding of interleukin 1 (IL-1)α and IL-receptor antagonist (IL-1ra) to human serum. High-affinity binding of IL-1ra to soluble IL-1 receptor type I
18. Plasma cytokines in acute stroke
19. Salt and blood pressure revisited
20. Anticoagulant therapy in cerebral thrombosis and cerebral embolism
21. Anticoagulant treatment in progressing stroke
22. Anticoagulant therapy in cerebral infarction. Report on a cooperative study
23. Temporal profile (clinical course) of acute carotid system cerebral infarction
24. Temporal profile (clinical course) of acute vertebrobasilar system infarction
25. Temporal profile of vertebrobasilar territory infarction. Prognostic implications
26. Progressive stroke caused by CT-verified small deep infarcts: Relation with the size of the infarct and clinical outcome
27. Intravenous heparin for the prevention of stroke in acute partial stroke
28. Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project